You are here: Industry Insights > Mylan

News List

Mylan launches MyHep All in India expressbpd
July 31, 2017
MyHep All is a fixed-dose combination of Velpatasvir 100 mg/ Sofosbuvir 400 mg tablets
FDA unanimously recommends Mylan and Biocon's Herceptin biosimilar pharmafile
July 17, 2017
Mylan and Biocon have revealed that their biosimilar version of Roche and Genentech’s Herceptin (trastuzumab) has received unanimous recommendation from the FDA’s Oncology Drugs Advisory Committee (ODAC) for the treatment of breast cancer.
Mylan-Biocon’s breast cancer biosimilar gets US FDA nod financialexpress
July 17, 2017
Mylan and Biocon’s proposed biosimilar trastuzumab also is under review by regulatory authorities in Australia, Canada, Europe and other emerging markets
Mylan-Biocon’s breast cancer biosimilar gets US FDA nod financialexpress
July 14, 2017
Mylan and Biocon’s proposed biosimilar trastuzumab also is under review by regulatory authorities in Australia, Canada, Europe and other emerging markets
Mylan's first-quarter profit rises, but sales increase misses estimates firstwordpharma
May 11, 2017
Mylan announced Wednesday that first-quarter profit reached $66.4 million, up from $13.9 million in the year-ago period. Meanwhile, sales jumped 24 percent year-over-year to $2.7 billion, although the figure fell short of analyst estimates of $2.8 billion
Mylan Provides Update on Expanded Voluntary Worldwide Recall of EpiPen® Auto-Injector americanpharmaceuticalreview
April 06, 2017
Mylan announced that Meridian Medical Technologies has expanded a voluntary recall of select lots of EpiPen (epinephrine injection, USP) and EpiPen Jr® (epinephrine injection, USP) Auto-Injectors...
Mylan Completes Acquisition of Cold-EEZE® Brand americanpharmaceuticalreview
March 31, 2017
Mylan has announced the successful acquisition of the global rights to the Cold-EEZE® brand cold remedy line from ProPhase Labs, Inc.
FDA rejects Mylan's generic version of GlaxoSmithKline's inhaled asthma drug Advair firstwordpharma
March 30, 2017
Mylan announced Wednesday that it received a complete response letter from the FDA regarding its regulatory filing to market a generic version of GlaxoSmithKline's Advair Diskus (fluticasone/salmeterol).
Mylan recalls 81,000 EpiPens after reports of failures pharmaphorum
March 24, 2017
Generics firm Mylan has recalled about 81,000 EpiPen devices in countries outside the US, after two reports the allergy injection device failed to work in emergencies.
Mylan receives tentative approval for "TLE400" under PEPFAR cphi-online
March 23, 2017
TLE400 is a fixed-combination containing Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 400 mg/300 mg/300 mg.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page